Seeing Is Believing

Currently out of the existing stock ratings of Jason Gurda, 7 are a BUY (100%).
Analyst Jason Gurda, carries an average stock price target met ratio of 83.33% that have a potential upside of 30.37% achieved within 350 days. Previously, Jason Gurda worked at KEYBANK.
Jason Gurda’s has documented 13 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on EVHC, Envision Healthcare Holdings at 14-Nov-2017.
Analyst best performing recommendations are on MD (MEDNAX).
The best stock recommendation documented was for EVHC (ENVISION HEALTHCARE HOLDINGS) at 11/14/2017. The price target of $40 was fulfilled within 107 days with a profit of $11.48 (40.25%) receiving and performance score of 3.76.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Mar-2017
$45
$-0.99 (-2.15%)
$85
8 years 7 months 7 days ago
(01-Mar-2018)
1/2 (50%)
$4.98 (12.44%)
168
Buy Since 12-Jun-2014
$41
$-4.99 (-10.85%)
$71
8 years 9 months 19 days ago
(19-Dec-2017)
3/8 (37.5%)
$7.86 (23.72%)
181
Hold Since 03-Dec-2015
$57
8 years 10 months 21 days ago
(17-Nov-2017)
2/5 (40%)
$2.65 (4.88%)
87
Buy Since 20-Aug-2015
$40
$-5.99 (-13.02%)
8 years 10 months 24 days ago
(14-Nov-2017)
1/2 (50%)
$11.48 (40.25%)
107
Buy Since 03-May-2017
$35
$-10.99 (-23.90%)
$73
8 years 10 months 24 days ago
(14-Nov-2017)
1/2 (50%)
$6.48 (22.72%)
49